Hypocarbia, also known as hypocapnia, is a decrease in alveolar and blood carbon dioxide (CO2) levels below the normal reference range of 35 mmHg. CO2 is a metabolic product of the many cellular processes within the body involved in the processing of lipids, carbohydrates, and proteins. The primary organ systems responsible for regulating CO2 homeostasis are the pulmonary system and the renal system. Additionally, CO2 is regulated through the CO2/HCO3 pH buffering system. Aberrations that lead to hypocarbia typically also result in respiratory alkalosis. This activity reviews the evaluation and management of hypocarbia and highlights the role of the interprofessional team in educating patients with this condition about follow-up care.
Hypocarbia, also known as hypocapnia, is a decrease in alveolar and blood carbon dioxide (CO2) levels below the normal reference range of 35 mmHg. CO2 is a metabolic product of the many cellular processes within the body involved in the processing of lipids, carbohydrates, and proteins. The primary organ systems responsible for regulating CO2 homeostasis are the pulmonary system and the renal system. Additionally, CO2 is regulated through the CO2/HCO3 pH buffering system. Aberrations that lead to hypocarbia typically also result in respiratory alkalosis.[x[rx]
Causes of Hypocarbia
At its root, hypocarbia is induced by either a decrease in CO2 production or an increase in CO2 loss.[rx Since metabolic demand does not typically decrease in a way that meaningfully adjusts CO2 levels into hypocarbia levels, the primary occurrence is a loss of CO2 via the pH buffering system or changes in the pulmonary system. The pulmonary system is highly efficient in its removal of CO2 from the body through gas diffusion. This requires a diffusion gradient from the high concentration arteriolar blood into the relatively low concentration environmental air. This gradient is maintained by continually washing away CO2 from the alveolar space, regardless of the absolute PaCO2 concentration. As such, the CO2 gradients are developed and maintained where PaCO2 in arterial blood is directly proportional to the rate of metabolic CO2 production and inversely related to the rate of CO2 elimination by the lung via increased alveolar ventilation. Alveolar ventilation is the removal of alveolar air into the environment, defined as the expired minute volume that reaches the alveoli and is determined by minute ventilation and the ratio of dead space to tidal volume. Mathematically, this relationship is determined as:
PaCO2 = 0.863 x VCO2/ VA
VA = VE – VD
VE = RR x TV
TV = RR x dead-space volume
Where VCO2 is the metabolic production of CO2, VA is alveolar ventilation, VE is minute ventilation, VD is dead space ventilation, RR is the respiratory rate, and TV is tidal volume.[rx]
Through these relationships, one can conclude that respiratory rate and tidal volume are the two components of ventilation that are physiologically or artificially controlled to moderate CO2 elimination. Subsequently, the etiologies that induce hypocarbia are any disease that increases ventilation rate or tidal volume. More commonly, the increased respiratory rate is the culprit. A wide variety of illnesses may induce this.
In almost every scenario, hypocarbia is synonymous with respiratory alkalosis as they are both induced by a process involving hyperventilation. These include:
Central sources are head injury, stroke, hyperthyroidism, anxiety-hyperventilation, pain, fear, stress, drugs, medications such as salicylates, and various toxins.
Hypoxic stimulation leads to hyperventilation in an attempt to correct hypoxia at the expense of CO2 loss.
Pulmonary causes include pulmonary embolisms, pneumothorax, pneumonia, and acute asthma or chronic obstructive pulmonary disease (COPD) exacerbations.
Hypocarbia is a result of hyperventilation. Increased ventilation to the alveolar space quickly removes gaseous CO2. This increases the diffusion gradient of CO2 from blood to alveoli. Subsequently, CO2 is more readily removed from the body. There are virtually no mechanisms outside of decreasing respiratory rate to regulate this loss. The partial pressure of carbon dioxide (PaCO2) is maintained between 35-45 mmHg with the help of feedback regulators. Central chemoreceptors (in the brain) and peripheral chemoreceptors (in the carotid bodies) sense the concentration of hydrogen and influence ventilation to regulate pH and PaCO2. For instance, if these receptors sense an increased concentration of hydrogen ions, ventilation is escalated to wash off CO2. If hyperventilation is persistent, it eventually leads to hypocapnia because alveolar ventilation exceeds the amount of CO2 being produced.
The estimation of change in pH with hyperventilation can be done with the help of the following:
Acute respiratory alkalosis: Change in pH = 0.008 x (40 – PaCO2)
Chronic respiratory alkalosis: Change in pH = 0.017 x (40 – PaCO2)
Diagnosis of Hypocarbia
Clinical presentation of hypocarbia depends on the duration, severity, and underlying cause of the illness. Since the underlying mechanism behind all the etiologies of hypocapnia is hyperventilation, many patients present with a complaint of shortness of breath. The exact history and physical exam findings are highly variable as many pathologies induce respiratory change. These may include acute onset dyspnea, fever, chills, peripheral edema, orthopnea, weakness, chest pain, wheezing, hemoptysis, trauma, history of central line catheter, recent surgery, history of thromboembolic disease, history of asthma, history of COPD, acute focal neurological signs, abdominal pain, nausea, vomiting, tinnitus, or weight loss.
Cerebral vasoconstriction secondary to hypocarbia may present with neurological symptoms such as dizziness, confusion, seizures, and syncope. However, these symptoms only manifest in the absence of hypoxemia.
Hyperventilation may also lead to painful tingling in the hands and feet, numbness, and sweating of the hands.
Hypocarbia also hampers vitamin D metabolism leading to hypovitaminosis D, which may present as fibromyalgias and tetany.
Depending on the etiology, physical exam findings may vary significantly.
Tachypnea is a frequent finding at presentation, as many patients with hyperventilation syndrome are anxious and tachycardic. The only difference between acute and chronic hypocarbia is that in an acute setting, patients tend to have chest wall movements and increased breathing rates. In contrast, in chronic states, these findings may not be apparent.
There may be positive Trousseau, and Chvostek signs secondary to respiratory alkalosis, which causes decreased serum calcium due to a shift of calcium from the blood to albumin, which has become more negative in the alkalotic state.
Several pulmonary diseases often present with hyperventilation and respiratory alkalosis. In such instances, the physical findings on chest examination would depend on the underlying pathology. For example, coarse crackles in pneumonia, wheezes, and rhonchi in asthma, or fine crackles in left ventricular failure and interstitial lung diseases.[rx]
With a wide preliminary differential diagnosis list, evaluation should always begin with a thorough history and physical exam to focus on diagnostic considerations. In all cases, arterial blood gas is crucial to diagnose any pH imbalances. Serum electrolytes should be measured particularly sodium, potassium, magnesium, phosphate, and calcium levels as aberrations in these may lead to further complications.
Bicarbonate concentration level declines by 2 mEq/L for each decrease of 10 mmHg in the PaCO2 level in the acute setting. However, in chronic cases, the bicarbonate level decreases by 5 mEq/L for each decline of 10 mmHg in the PaCO2 level. Nevertheless, bicarbonate levels usually never decline below 12 mmHg in compensated primary respiratory alkalosis.
In hypoxic patients, it is important to calculate the A-a gradient to determine the etiology and further diagnosis. If the A-a gradient is wide, be suspicious of pulmonary embolism and appropriately investigate the patient.
A chest x-ray is important in all patients as it helps discern an anatomical or infectious cause and may rule in/out pulmonary edema. If there is a clinical reason for it, chest computed tomography (CT) can play a vital role in achieving a diagnosis
If there is appropriate clinical suspicion for neurological insult, CT or magnetic resonance imaging (MRI) of the head may be appropriate along with lumbar puncture for white blood cell (WBC), glucose, and protein analysis.[rx][rx]
Treatment of Hypocarbia
Treatment of hypocapnia is targeted at treating the underlying pathology to reduce the respiratory rate if possible. Historically treatment involved rebreathing into a paper bag to increase alveolar CO2. However, this has been shown to increase undesirable outcomes including mortality and is no longer recommended. In anxious patients, anxiolytics may be necessary. In an infectious disease, antibiotics targeting sputum or blood cultures are appropriate. In embolic disease, anticoagulation is necessary. Ventilator support may be necessary for patients with acute respiratory failure, acute asthma, or acute COPD exacerbation if they show signs of respiratory fatigue. In ventilator-controlled patients, it may be necessary to reevaluate their ventilator settings to reduce respiratory rate. If hyperventilation is intentional, monitor the arterial or venous blood gas values closely. In severe cases, pH may be directly reduced using acidic agents; however, this is not routinely performed.rx